Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia

Blood

Volumn 88, Issue 6, 1996, Pages 2162-2171

  Petzer, Andreas L ^b   Eaves, Connie J ^b   Lansdorp, Peter M ^b   Ponchio, Luisa ^b   Barnett, Michael J ^b   Eaves, Allen C ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD71 ANTIGEN; LEUKOCYTE ANTIGEN; THY 1 ANTIGEN;

ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0029837399     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2162.bloodjournal8862162     Document Type: Article

References (41)

1. Groffen J, Heisterkamp N: The BCR/ABL hybrid gene. Clin Haematol 1:983, 1995
2. Van Etten RA, Jackson P, Baltimore D: The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669, 1989
3. Sawyers CL: The bcr-abl gene in chronic myelogenous leukaemia. Cancer Surv 15:37, 1992
4. Raskind WH, Fialkow PJ: The use of cell markers in the study of human hematopoietic neoplasia. Adv Cancer Res 49:127, 1987
5. + chronic myelogenous leukemia and effects of intensive treatment. Blood 59:793, 1982
6. Coulombel L, Kalousek DK, Eaves CJ, Gupta CM, Eaves AC: Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med 308:1493, 1983
7. Talpaz M, Kantarjian HM, McCredie K: Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N Engl J Med 314:1065, 1986
8. + cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
9. Sirard C, Lapidot T, Vormoor J, Cashman JD, Doedens M, Murdoch B, Jamal N, Messner H, Addey L, Minden M, Laraya P, Keating A, Eaves A, Lansdorp PM, Eaves CJ, Dick JE: Normal and leukemic SCID-repopulating cells (SRC) co-exist in the bone marrow and peripheral blood from CML patients in chronic phase while leukemic SRC are detected in blast crisis. Blood 87:1539, 1996
10. Verfaillie CM, Miller WJ, Boylan K, McGlave PB: Selection of benign primitive hemalopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003, 1992
11. Eaves AC, Cashman JD, Gaboury LA, Kalousek DK, Eaves CJ: Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. Proc Natl Acad Sci USA 83:5306, 1986
12. Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC: Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc Natl Acad Sci USA 89:6192, 1992
13. Udomsakdi C, Eaves CJ, Lansdorp PM, Eaves AC: Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia. Blood 80:2522, 1992
14. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF: Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 328:342, 1987
15. Verfaillie CM, McCarthy JB, McGlave PB: Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. J Clin Invest 90:1232, 1992
16. Verfaillie CM, Miller W, Miller JS, Bhatia R, McGlave PB: Benign primitive progenitors can be selected on the basis of the CD34+HLA-DR-phenotype in early chronic phase (ECP) but not advanced phase (AP) CML. Blood 84:382a, 1994 (abstr, suppl 1)
17. lo population in chronic myeloid leukemia: An analysis using interphase fluorescence in situ hybridization. Blood 86:737, 1995
18. Leemhuis T, Leibowitz D, Cox G, Silver R, Srour EF, Tricot G, Hoffman R: Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood 81:801, 1993
19. Craig W, Kay R, Cutler RL, Lansdorp PM: Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med 177:1331, 1993
20. - progenitor cells in long-term cultures and semisolid assays. Blood 81:2916, 1993
21. + subpopulations of human bone marrow cells. Proc Natl Acad Sci USA 91:12223, 1994
22. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996
23. + cells in serum-free cultures initiated with highly purified progenitor cells from human bone marrow. J Exp Med 175:1501, 1992
24. Hogge D, Reid D, Gerhard B, Lansdorp P, Eaves C: Murine fibroblasts producing human steel factor (SF), IL-3 and G-CSF can enhance the maintenance of human longterm culture-initiating cells (LTC-IC) and their output of clonogenic cells (CFC). Blood 86:493a, 1995 (abstr, suppl 1)
25. Ponchio L, Conneally E, Eaves C: Quantitation of the quiescent fraction of long-term culture-initiating cells (LTC-IC) in normal human blood and marrow and the kinetics of their growth factor-stimulated entry into S-phase in vitro. Blood 86:3314, 1995
26. Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584, 1990
27. Sutherland HJ, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE: Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78:666, 1991
28. Fraser C, Eaves CJ, Kalousek DK: Fluorodeoxyuridine synchronization of hemopoietic colonies. Cancer Genet Cytogenet 24:1, 1987
29. Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A: The biology of normal and neoplastic stem cells in CML. Leuk Lymphoma 11:245, 1993 (suppl 1)
30. Singer JW, Fialkow PJ, Steinmann L, Najfeld V, Stein SJ, Robinson WA: Chronic myelocytic leukemia (CML): Failure to detect residual normal committed stem cells in vitro. Blood 53:264, 1979
31. Kalousek DK, Eaves CJ, Eaves AC: In-vitro cytogenetic studies of haemopoietic malignancies. Cancer Surv 3:439, 1984
32. Petzer A, Ponchio L, Ghaffari S, Cashman J, Lansdorp P, Eaves A, Eaves C: Mobilization of normal LTC-IC in the blood of untreated CML patients with high WBC counts. Blood 84:400a, 1994 (abstr, suppl 1)
33. Dube ID, Gupta CM, Kalousek DK, Eaves CJ, Eaves AC: Cytogenetic studies of early myeloid progenitor compartments in Ph1-positive chronic myeloid leukaemia (CML). I. Persistence of Ph1-negative committed progenitors that are suppressed from differ-entiating in vivo. Br J Haematol 56:633, 1984
34. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, Blume KG: Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after highdose chemotherapy. Blood 81:2031, 1993
35. Korbling M, Burke P, Braine H, Elfenbein G, Santos G, Kaizer H: Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol 9:684, 1981
36. Carella AM, Podesta M, Frassoni F, Raffo MR, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C, Rabitti C, Ferrero R, Benvenuto F, Figari O, Carlier P, Levcasic G, Valbonesi M, Vitale V, Giordano D, Pierluigi D, Nati S, Guerracio A, Rosso C, Saglio G: Collection of "normal" blood repopulating cells during early hematopoeietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia, Bone Marrow Transplant 12:267, 1993
37. Brito-Babapulle F, Bowcock SJ, Marcus RE, Apperley J, Th'ng KH, Dowding C, Rassool F, Guo AP, Catovsky D, Galton DAG, McCarthy D, Goldman JM: Autografting for patients with chronic myeloid leukaemia in chronic phase: Peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis. Br J Haematol 73:76, 1989
38. Barnett MJ, Eaves CJ, Phillips GL, Kalousek DK, Klingemann H-G, Lansdorp PM, Reece DE, Shepherd JD, Shaw GJ, Eaves AC; Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture. Bone Marrow Transplant 4:345, 1989
39. Barnett MJ, Eaves CJ, Phillips GL, Gascoyne RD, Hogge DE, Horsman DE, Humphries RK, Klingemann H-G, Lansdorp PM, Nantel SH, Reece DE, Shepherd JD, Spinelli JJ, Sutherland HJ, Eaves AC: Autografting with cultured marrow in chronic myeloid leukemia: Results of a pilot study. Blood 84:724, 1994
40. + cells from patients with chronic myeloid leukemia. Blood (in press)
41. -) LTC-IC. Exp Hematol (in press)